Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
2nd Annual Scientific Meeting on Vasculitis
Montréal Centre Mont-Royal
22 November 2012
Part 1 ‐ 8:30 to 10:45AM8:40 ‐ Large vessel vasculitides
Clinical updates in LVV – Dr. Nader KhalidiUpdates on LVV treatment – Dr. Patrick Liang
9:20 ‐ ANCA testing: how do we know the result is reliable – Dr. Donglai Ma (Euroimmun)
9h50 – ANCA‐associated vasculitidesClinical updates and gold‐standard therapy – Dr. Simon CaretteRituximab and biologics – Dr. Michelle Goulet
10h45 – 10 minutes Break
Part 2 ‐ 11:00AM to 12:05PMVasculitis STUDIES in Canada and CanVasc projects
Ongoing CanVasc activities and studies ‐ Dr. Christian PagnouxOpportunities for vasculitis studies in Canada – Dr. Susan Benseler
Ongoing non‐CanVasc studies in Canada ‐ Dr. Christian Pagnoux
12h05 – 13h15 Lunch
Part 3 & 4 ‐ 1:15 to 2:45PM1h15 ‐ CanVasc Website
‐ Dr. Christian Pagnoux
1h25 ‐ Imaging in vasculitides (LVV): PET and MRI ‐ Dr. Ryan Rebello
1h55 ‐ ANCA‐ Associated Vasculitis : The Cambridge (U.K.) experience – Dr. Rachel Jones
2h45 – 10 minutes Break
Part 5 & 6 ‐ 3:00 to 5:00PM3h00 ‐ CNS vasculitisPediatric CNS vasculitis and BrainWorks – Dr. Susan Benseler
Adult CNS vasculitis and InterSpace – Dr. Sylvain Lanthier
3h45 ‐Meet the Experts: difficult vasculitis cases – Panel of CanVasc core members
4h45 Conclusion
Thanks to the following pharmaceutical companies for their funding support
PLATINUM SUPPORT
Abbott Immunology
Janssen‐Cilag
Euroimmun
Pfizer/Amgen
SILVER SUPPORT
Hoffman ‐ La Roche
Toronto2014